Results 91 to 100 of about 27,811 (250)

Maternal sleep disorders during pregnancy and subsequent risk of allergic diseases in Japanese children: the TMM BirThree Cohort Study [PDF]

open access: yesClinical and Experimental Pediatrics
Background Associations have been suggested between prenatal exposure and allergic diseases in children as well as between respiratory allergies and maternal sleep disorders during pregnancy.
Ami Uematsu   +7 more
doaj   +1 more source

A survey on features of allergic rhinitis in children [PDF]

open access: yes, 2013
Objective: A number of epidemiologic studies evaluated the prevalence of allergic rhinitis (AR), but few data are available on its different clinical presentations.
),   +11 more
core   +1 more source

Treatment of patients with allergic conjunctivitis: experience of an outpatient ophthalmologist [PDF]

open access: yesКлиническая офтальмология
G.A. Azamatova1, G.R. Altynbaeva2 1Bashkir State Medical University, Ufa, Russian Federation 2City Clinical Hospital No. 5 of the city of Ufa, Ufa, Russian Federation Allergic conjunctivitis (AC) is one of the common eye diseases.
G.A. Azamatova, G.R. Altynbayeva
doaj  

Frequency of Sensitization to Aeroallergens in Patients with Seasonal and Perennial Allergic Conjunctivitis

open access: yesRevista Alergia México, 2014
Background: Allergic conjunctivitis is an in ammatory disease which involves the conjunctiva, its physiopathology is a type I hypersensitivity (IgE mediated). It is related to the sensitization to indoors and out- doors aeroallergens.
Guillermina Cortés-Morales   +3 more
doaj   +1 more source

Immunopathology of Allergic Conjunctivitis

open access: yesEuropean Medical Journal, 2018
Allergic conjunctivitis is predominantly an immunoglobulin E-mediated hypersensitivity reaction to environmental allergens. Allergic diseases affect >30% of the world’s population, of which 40% report associated ocular manifestations. Cellular and soluble mediators play a major role in the pathophysiology of allergic conjunctivitis.
DeGaulle I. Chigbu, Bhawanjot K. Minhas
openaire   +2 more sources

Efficacy and Safety of Anti‐IL‐4Rα Stapokibart in Elderly Patients With Moderate‐To‐Severe Atopic Dermatitis

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Elderly patients with moderate‐to‐severe atopic dermatitis (AD) often exhibit more heterogeneous inflammatory profiles compared with younger adults. To evaluate the efficacy and safety of stapokibart, an anti‐interleukin‐4 receptor α subunit (IL‐4Rα) monoclonal antibody, in different age subgroups.
Yan Zhao   +26 more
wiley   +1 more source

Minimal Disease Activity as A New Therapeutic Target in Atopic Dermatitis: A 5‐Year Real‐Life Experience With Dupilumab

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant physical and psychosocial burden. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has proven to be effective for moderate‐to‐severe AD, but long‐term real‐world data remain limited.
Francesco Leo   +11 more
wiley   +1 more source

Conjunctivitis: Types, Clinical Manifestation and Management

open access: yesJLUMHS
This narrative review analyses the different types, clinical manifestations, and management strategies for conjunctivitis to facilitate accurate diagnosis and treatment planning.
Mehwish Rubab, Sana Zahoor, Saba Ashraf
doaj   +1 more source

Release of Mast Cell Tryptase into Saliva: A Tool to Diagnose Food Allergy by a Mucosal Challenge Test? [PDF]

open access: yes, 2011
Background: Our aim was to examine whether measurement of the saliva mast cell tryptase (MCT) concentrations before and after a mucosal challenge test with the offending food would be helpful in diagnosing food allergy.
Alexander Arnold   +11 more
core   +1 more source

Biomarkers for therapeutic response and adverse outcomes in atopic dermatitis: A systematic review

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This review assessed 52 biomarkers predicting systemic therapy response and adverse events in atopic dermatitis. Most studies focused on dupilumab, and findings were inconsistent. IgE and eosinophils were largely non‐predictive, though elevated eosinophils and LDH sometimes indicated poorer outcomes.
Eva Hilger   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy